As of April 2025 Rigel Pharmaceuticals has a market cap of ยฃ0.22 Billion. This makes Rigel Pharmaceuticals the world's 7485th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | ยฃ0.22 B | -1.24% |
2024 | ยฃ0.23 B | 16.7% |
2023 | ยฃ0.19 B | -7.39% |
2022 | ยฃ0.21 B | -36.17% |
2021 | ยฃ0.33 B | -22.63% |
2020 | ยฃ0.43 B | 58.27% |
2019 | ยฃ0.27 B | -9.49% |
2018 | ยฃ0.30 B | -27.98% |
2017 | ยฃ0.42 B | 120.38% |
2016 | ยฃ0.19 B | 3.07% |
2015 | ยฃ0.18 B | 44.24% |
2014 | ยฃ0.12 B | -15.11% |
2013 | ยฃ0.15 B | -56.85% |
2012 | ยฃ0.35 B | -3.1% |
2011 | ยฃ0.36 B | 41.84% |
2010 | ยฃ0.25 B | -16.5% |
2009 | ยฃ0.30 B | 52.9% |
2008 | ยฃ0.19 B | -50.21% |
2007 | ยฃ0.40 B | 162.84% |
2006 | ยฃ0.15 B | 26.85% |
2005 | ยฃ0.12 B | -51.9% |
2004 | ยฃ0.25 B | 57.13% |
2003 | ยฃ0.15 B | 407.17% |
2002 | ยฃ31.38 M | -74.07% |
2001 | ยฃ0.12 B | -50.93% |
2000 | ยฃ0.24 B |
On Apr 6th, 2025 the market cap of Rigel Pharmaceuticals was reported to be: